Vimarsana
Biggest News Aggregation in the World

Page 12 - Dave Fredrickson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dave Fredrickson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dave Fredrickson Today - Breaking & Trending Today

British drug found to halve risk of dying from lung cancer - Vimarsana News

British drug found to halve risk of dying from lung cancer

A drug from British pharmaceutical giant has been found to reduce the risk of dying from certain types of lung cancer.

AstraZeneca's lung cancer pill cuts risk of death by half, study finds - Vimarsana News

AstraZeneca's lung cancer pill cuts risk of death by half, study finds

The drug, developed by AstraZeneca, if taken daily after surgery, dramatically reduces risk of death, study shows.

Source: news24.com
AstraZeneca's Tagrisso Slashes Death Risk in Lung Cancer - Vimarsana News

AstraZeneca's Tagrisso Slashes Death Risk in Lung Cancer

The therapy cut the risk of death by more than half in patients with a certain form of lung cancer who were diagnosed early enough to have their tumour surgically removed, trial data showed.

AstraZeneca's Tagrisso slashes death risk in certain post-surgery lung cancer patients - Vimarsana News

AstraZeneca's Tagrisso slashes death risk in certain post-surgery lung cancer patients

AstraZeneca's lung cancer therapy, Tagrisso, cut the risk of death by more than half in patients with a certain form of lung cancer who were diagnosed early enough to have their tumour surgically... | June 4, 2023

AstraZeneca gets another US approval for Lynparza - Vimarsana News

AstraZeneca gets another US approval for Lynparza

AstraZeneca has received approval in the United States for the drug combination of ‘Lynparza’, or olaparib, with abiraterone and prednisone or prednisolone for the treatment of adult patients suffering from metastatic castration-resistant prostate cancer (mCRPC) with deleterious or suspected deleterious BRCA mutations, it announced on Thursday.